Livopill Tablet is a combination pharmaceutical formulation containing Metadoxine 250 mg, Silymarin 70 mg, and L-Ornithine L-Aspartate 75 mg, designed to support liver function and promote hepatic regeneration. Metadoxine acts as a hepatoprotective agent by accelerating the metabolism and clearance of toxic substances, particularly in cases of acute and chronic liver disorders, including alcoholic liver disease. Silymarin, a flavonoid complex extracted from milk thistle, exhibits potent antioxidant and anti-inflammatory properties, stabilizing hepatocyte membranes and facilitating liver tissue repair. L-Ornithine L-Aspartate contributes to ammonia detoxification by enhancing the urea cycle, thereby reducing hyperammonemia commonly associated with hepatic encephalopathy and other liver dysfunctions. The synergistic action of these active ingredients makes Livopill Tablet effective in managing various hepatic conditions, improving liver enzyme profiles, and alleviating symptoms related to liver impairment. It is indicated for use in patients with liver cirrhosis, fatty liver disease, and toxic hepatitis. Administration should be under medical supervision, with dosage adjusted according to the severity of the condition and patient response. Livopill Tablet should be used cautiously in patients with known hypersensitivity to any component and in those with severe renal impairment.